Congratulations! You now have unlimited access to all articles from The Ophthalmologist.
Complete your profile at your earliest convenience to unlock the rest of your benefits:
relevant and personalised updates about your field
access to Case Studies/product profiles
digital magazine subscription
In the March issue, Upfront’s topics range from the two-year Protocol T results, to a potentially electrifying adult amblyopia treatment. The cover feature tells the story of NGF: the polymath molecule, which has potential applications from cornea to retina. In Practice sees Mitch Jackson and David Chang debate FLACS, and in NextGen we benchmark corneal OCT. Profession sees Hakam Ghabra discuss turning “What If?” to “Why Not?” – to an IOL prototype, and we Sit Down With Anat Loewenstein, Chair of Ophthalmology, Tel Aviv Medical Centre, Israel.